Researchers at Harvard report the creation of "cyborg organoids", which consist of 3D organoids grown from stem cells, with embedded sensors to measure activity in the developmental process.
This week, Elon Musk's company Neuralink applied to U.S. regulators to begin trials of a new brain enhancement technology, which could be tested on human volunteers from 2020.
Veritas Genetics made headlines in 2016 by breaking the $1,000 barrier for whole genome sequencing. Now, the company is set to disrupt the genetic testing industry once again.
